Lorcaserin

FDA

• Indicated for obese patients with an initial body mass index (BMI) ≥ 30 kg/m², or overweight patients with a BMI ≥ 27 kg/m² in the presence of at least one weight related comorbid condition (e.g., hypertension, dyslipidemia, cardiovascular disease, glucose intolerance, sleep apnea) for weight loss and maintenance of weight loss
• Approved for use only in conjunction with a reduced-calorie diet and a program of regular exercise
• Approved for adults, age 18 and older